Abstract:Gut microbes and their metabolites are actively involved in the development and regulation of host immunity, which can influence disease susceptibility. Herein, we review the most recent research advancements in the gut microbiota–immune axis. We discuss in detail how the gut microbiota is a tipping point for neonatal immune development as indicated by newly uncovered phenomenon, such as maternal imprinting, in utero intestinal metabolome, and weaning reaction. We describe how the gut microbiota shapes both innate and adaptive immunity with emphasis on the metabolites short-chain fatty acids and secondary bile acids. We also comprehensively delineate how disruption in the microbiota–immune axis results in immune-mediated diseases, such as gastrointestinal infections, inflammatory bowel diseases, cardiometabolic disorders (e.g., cardiovascular diseases, diabetes, and hypertension), autoimmunity (e.g., rheumatoid arthritis), hypersensitivity (e.g., asthma and allergies), psychological disorders (e.g., anxiety), and cancer (e.g., colorectal and hepatic). We further encompass the role of fecal microbiota transplantation, probiotics, prebiotics, and dietary polyphenols in reshaping the gut microbiota and their therapeutic potential. Continuing, we examine how the gut microbiota modulates immune therapies, including immune checkpoint inhibitors, JAK inhibitors, and anti-TNF therapies. We lastly mention the current challenges in metagenomics, germ-free models, and microbiota recapitulation to a achieve fundamental understanding for how gut microbiota regulates immunity. Altogether, this review proposes improving immunotherapy efficacy from the perspective of microbiome-targeted interventions.

The crosstalk between gut bacteria and host immunity in intestinal inflammation

Microbiota Regulation of Inflammatory Bowel Disease and Colorectal Cancer

Interplay of Intestinal Microbiota and Mucosal Immunity in Inflammatory Bowel Disease: a Relationship of Frenemies

The Crosstalk Between Intestinal Bacterial Microbiota and Immune Cells in Colorectal Cancer Progression

Nutrients Mediate Intestinal Bacteria–Mucosal Immune Crosstalk

Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease.

Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease

[Interactions between the monogastric animal gut microbiota and the intestinal immune function--a review]

Crosstalk Between The Immune Receptors and Gut Microbiota

Interaction between microbiota and immunity in health and disease

Interaction Between Microbes and Host Intestinal Health: Modulation by Dietary Nutrients and Gut-Brain-Endocrine-Immune Axis

Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease

Inflammatory Bowel Disease: A Potential Result from the Collusion Between Gut Microbiota and Mucosal Immune System

Interaction between microbiota and immunity and its implication in colorectal cancer

Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens

Interaction Between the Gut Microbiome and Mucosal Immune System

Recent Advances in the Interactions between Animal Gut Microbiota and Host Intestinal Immune System

Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy

The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes

Interaction between Intestinal Microflora and Intestinal Immune System of Host and Its Possible Mechanisms in Monogastric Animals

The lung-gut crosstalk in respiratory and inflammatory bowel disease